Robert Lance Fine
Impact in
Papers in
- Oncology 52
- Drug Transport and Resistance Mechanisms 22
- Pancreatic and Hepatic Oncology Research 14
- Cancer-related Molecular Pathways 13
-
- Cancer therapeutics and mechanisms 7
- Cell death mechanisms and regulation 7
- Biochemical and Molecular Research 5
- Co-authors
- Bruce Allan Chabner (9 shared papers)Elizabeth Robins Gerstner (1 shared paper)Alok A. Khorana (1 shared paper)Clifford W. Sachs (8 shared papers)Dung‐Tsa Chen (1 shared paper)Junsung Choi (1 shared paper)Aejaz Nasir (1 shared paper)Jonathan Strosberg (1 shared paper)
- Journals
- Journal of Biological Chemistry (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)Cancer (6 papers)Biochemical Pharmacology (6 papers)Neurosurgery (5 papers)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Robert Lance Fine
103 papers receiving 6.4k citations
Robert Lance Fine's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.3k
- Genetics 399
- Epidemiology 841
- Internal Medicine 67
- Molecular Biology 1.4k
Countries citing papers authored by Robert Lance Fine
This map shows the geographic impact of Robert Lance Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lance Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lance Fine more than expected).
Fields of papers citing papers by Robert Lance Fine
This network shows the impact of papers produced by Robert Lance Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lance Fine. The network helps show where Robert Lance Fine may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lance Fine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas Hit paper breakdown → | 2010 | 603 |
| 2 | Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes –Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer Hit paper breakdown → | 2015 | 530 |
| 3 | 1988 | 223 | |
| 4 | 2007 | 223 | |
| 5 | 2004 | 212 | |
| 6 | 2013 | 211 | |
| 7 | 1992 | 193 | |
| 8 | 1987 | 190 | |
| 9 | 2010 | 174 | |
| 10 | Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. | 1995 | 172 |
| 11 | 1996 | 162 | |
| 12 | 1993 | 160 | |
| 13 | 2011 | 130 | |
| 14 | 1986 | 127 | |
| 15 | 1994 | 106 | |
| 16 | 1999 | 104 | |
| 17 | 1996 | 89 | |
| 18 | 1995 | 88 | |
| 19 | 1996 | 88 | |
| 20 | 2000 | 88 |
About Robert Lance Fine
Robert Lance Fine is a scholar working on Oncology, Molecular Biology, Genetics, Neurology and Otorhinolaryngology, having authored 104 papers that have together received 6.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related Molecular Pathways (13 papers), Cancer therapeutics and mechanisms (7 papers), Glioma Diagnosis and Treatment (7 papers), Cell death mechanisms and regulation (7 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Oncology (2.3k citations), Genetics (399 citations), Epidemiology (841 citations), Internal Medicine (67 citations) and Molecular Biology (1.4k citations). Robert Lance Fine has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Bruce Allan Chabner, Elizabeth Robins Gerstner, Alok A. Khorana, Clifford W. Sachs, Dung‐Tsa Chen, Junsung Choi, Aejaz Nasir, Jonathan Strosberg, Domenico Coppola and Jitendra B. Patel. Their work appears in journals such as Journal of Biological Chemistry, Cancer Chemotherapy and Pharmacology, Cancer, Biochemical Pharmacology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.